Paper Details

  1. Home
  2. Paper Details

Antibody therapies for lymphoma in children.

Author: GouwSamantha C, Meyer-WentrupFriederike A G, de ZwartVerena

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Lymphoma is a common cancer in children, with high cure rates, but further improvements are needed. While antibody therapies have been successful for adults with lymphoma, none are currently approved for children.
Paper Details　
Original Abstract of the Article :
Lymphomas are the third most common malignancy in childhood. Cure rates are high but have reached a plateau. Therefore new treatment modalities should be developed. Antibody therapy is a successful new treatment option in adult lymphoma. However, none of the therapeutic antibodies available for adul...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719646/

データ提供：米国国立医学図書館（NLM）

Antibody Therapies for Lymphoma in Children: A New Frontier in Cancer Treatment

Lymphoma, like a creeping desert sandstorm, can be a formidable challenge for children. This study explores the potential of antibody therapy, a promising new approach to cancer treatment, in combating lymphoma in children. The authors discuss the current state of antibody therapy for lymphoma in children, highlighting the need for new treatment modalities to improve outcomes.

Antibody Therapy: A Potential Breakthrough

The study highlights the potential of antibody therapy as a new treatment option for children with lymphoma. This discovery is like finding a new weapon in the fight against this disease, offering a potential path toward remission. The authors acknowledge that while antibody therapy has proven effective in adults, further research is needed to determine its safety and efficacy in children.

The Need for Continued Research

The study underscores the need for continued research to develop antibody therapies specifically tailored for children with lymphoma. This research, like a desert explorer charting a new course, is essential for improving the treatment options available for children battling this disease. The study emphasizes the importance of finding safe and effective treatments that can provide children with the best possible chance for a cure.

Dr. Camel’s Conclusion

This research offers a glimmer of hope in the fight against childhood lymphoma. The study highlights the potential of antibody therapy as a new weapon in our arsenal, reminding us that the fight against cancer is an ongoing journey, filled with both challenges and opportunities. The study underscores the importance of investing in research to develop new and effective treatments for children, ensuring that they have access to the best possible care.

Date :
  1. Date Completed 2016-05-10
  2. Date Revised 2023-11-08
Further Info :

Pubmed ID

26784573

DOI: Digital Object Identifier

PMC8719646

Related Literature

Article Analysis
・Effective treatment of lymphoma
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.